Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(852/week)
    • Manufacturing(421/week)
    • Energy(323/week)
    • Technology(827/week)
    • Other Manufacturing(261/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Imidazoles

May 14, 2020
SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome
Mar 09, 2020
The irritable bowel syndrome treatment market was valued at $1,071 million in 2018, and is estimated to reach at $2,012 million by 2026, registering a CAGR of 8.2% from 2019 to 2026
Dec 10, 2019
Slayback Pharma announces approval and immediate launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in 200 mcg/ 50 mL and 400 mcg/ 100 mL (4 mcg/mL) vials, generic equivalent of Precedex(TM) 4 mcg/ mL
Sep 04, 2018
Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna®(nilotinib)
Jun 06, 2018
Daiichi Sankyo's U.S. Products Liability Litigation Settlement Program Moves Forward; More than 97 Percent of Eligible Litigants and Claimants Opt In
Jun 02, 2018
New Novartis data presented at ASCO find nearly half of CML patients treated with Tasigna® remain in remission almost three years after stopping therapy
Mar 22, 2018
Novartis drug Tasigna® approved by FDA to treat children with rare form of leukemia
Feb 23, 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA® (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Aug 22, 2017
Teikoku Pharma USA Announces Positive Topline Results from Phase 2 Clinical Trial of TPU-006, Non-Opioid Pain Management Patch in Bunionectomy Surgery
Aug 01, 2017
Daiichi Sankyo Announces Settlement Agreement on U.S. Products Liability Litigation
Jun 19, 2017
FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA® (denosumab) To Include Multiple Myeloma Patients
Jun 04, 2017
Amgen Presents New Data From Phase 3 XGEVA® (Denosumab) Study In Patients With Multiple Myeloma At ASCO 2017

Latest News

Jul 10, 2025

Ionic Mineral Technologies Closes Oversubscribed $29 Million Series B to Scale U.S. Production of Advanced...

Jul 10, 2025

E3 Lithium Announces Arrival of Equipment for the Demonstration Facility at the Clearwater Project Site

Jul 10, 2025

QAD | Redzone Supercharges EMEA Expansion with Appointment of Ahmad Salama as General Manager

Jul 10, 2025

IFF Expands Innovation Center in Singapore with New Immersive Experience Hub

Jul 10, 2025

Northrop Grumman Completes Key Test for Exoplanetary Ascent Propulsion

Jul 10, 2025

Protected logistics truck: Rheinmetall MAN Military Vehicles presents new TGS-Mil Protected

Jul 10, 2025

RTX's Raytheon demonstrates autonomous capabilities of its Barracuda mine neutralizer

Jul 10, 2025

Murata Begins World’s First Mass Production of 47μF Multilayer Ceramic Capacitor in 0402-inch Size

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia